Efficacy and Safety of Pioglitazone in a Phase 1/2 Imatinib...

  • Main
  • 2020 / 08
  • Efficacy and Safety of Pioglitazone in a Phase 1/2 Imatinib...
American Journal of Hematology 2020 / 08

Efficacy and Safety of Pioglitazone in a Phase 1/2 Imatinib Discontinuation Trial ( EDI‐PIO ) in Chronic Myeloid Leukemia with Deep Molecular Response

Pagnano, Katia B.B., Lopes, Ana Beatriz P., Miranda, Eliana C., Delamain, Márcia T., Duarte, Gislaine O., Rodrigues, Bruna R.V., Povoa, Valquiria M.O., Furlin, Graziele C.P., Vianna, Jessica C., Silv
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
American Journal of Hematology
DOI:
10.1002/ajh.25986
Date:
August, 2020
File:
PDF, 918 KB
2020
Conversion to is in progress
Conversion to is failed